Coronary

View the latest content related to this topic

News Daily News

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

The DECADE data show a higher risk of death, MI, and stent thrombosis in people who smoked at the time of PCI with DES.

Yael L. Maxwell

March 24, 2025

Slides

See all

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation ACC 2025

Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial

Presenter: Joo-Yong Hahn

March 29, 2025

Presentation ACC 2025

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

Presenter: Hyo-Soo Kim

March 29, 2025

Presentation CTO 2025

Efficacy and Safety of Left Ventricular Assist Devices on Clinical Outcomes in High-Risk Percutaneous Coronary Interventions

Presenter: Ogechukwu Samuel Obi

March 01, 2025

Presentation CTO 2025

Sex-Based Differences on Clinical Outcomes in High-Risk Percutaneous Coronary Intervention with Left Ventricular Assist Devices

Presenter: Ogechukwu Samuel Obi

March 01, 2025

News

See all

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

By Michael O'Riordan

March 29, 2025

News Conference News ACC 2025

WARRIOR: No Clear Answers on How to Best Treat INOCA

By Yael L. Maxwell

March 29, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

By Michael O'Riordan

March 26, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

By Michael O'Riordan

March 26, 2025

News Daily News

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

By Yael L. Maxwell

March 24, 2025

AHA 2024

November 16

November 18, 2024

TCT 2024

October 27

October 30, 2024

ESC Congress 2024

August 30

September 02, 2024

Videos on This Topic

See all

Advertisement

Coronary

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

Slides

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

Efficacy and Safety of Left Ventricular Assist Devices on Clinical Outcomes in High-Risk Percutaneous Coronary Interventions

Sex-Based Differences on Clinical Outcomes in High-Risk Percutaneous Coronary Intervention with Left Ventricular Assist Devices

News

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

WARRIOR: No Clear Answers on How to Best Treat INOCA

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

What’s Going to Be Hot at ACC 2025?

The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis

More on This Topic

Conference Coverage

AHA 2024

TCT 2024

ESC Congress 2024

Videos on This Topic

Advertisement

Coronary

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content